Screening for cognitive impairment in adults with sickle cell disease: a systematic review and meta-analysis

We report a pooled prevalence of 38% [14-62%] of suspected cognitive impairment. We discuss the relative benefits and limitations of the different screening tools to help clinicians select an adapted approach tailored to their specific patients' needs. Further studies are needed to establish and validate cognitive screening strategies in patients with diverse cultural and educational backgrounds.PMID:37979834 | DOI:10.1016/j.lpm.2023.104207

Source: Presse Medicale - November 18, 2023 Category: General Medicine Authors: Maryline Couette Justine Roy Damien Oudin Doglioni Olena Bereznyakova Christian Stapf Gregory Jacquin Val érie Fraïle Philippe Desmarais Sara-Maude Desforges Lahoud Touma B énédicte Nauche Pablo Bartolucci Kevin H M Kuo St éphanie Forté Source Type: research